Galicia has established itself as one of the most dynamic emerging bioregions in Southern Europe, driven by a combination of scientific excellence, business growth, and an innovation ecosystem that is increasingly competitive on an international level.
Over the last decade, Galicia has doubled its number of biotechnology companies and successfully integrated this science into the regional economy.
More than 160 companies use biotechnology on a regular basis, and over 360 incorporate it into their production processes, demonstrating its cross-sector impact.
This sustained growth reflects a vibrant ecosystem with the ability to attract talent, create new companies, and scale innovative projects.
The development of the biotechnology sector in Galicia is supported by a long-term strategic vision driven by public administration.
The Biotechnology Sector Consolidation Strategy 2021–2025 has mobilised more than €600 million to strengthen the business fabric, boost innovation, and consolidate scientific capabilities.
In this same direction, Galicia is already working on the future Biotechnology Excellence Strategy 2026–2030, aimed at:
Biotechnology is already a strategic sector in Galicia, with a growing and measurable economic impact:
In recent years, sector turnover has quadrupled, exceeding €2 billion, driven by a combination of leading companies and a growing network of innovative SMEs.
This growth reflects the maturity of the ecosystem and its ability to generate real economic value.
Galician universities and research centers are constant generators of spin-offs and new companies, which drives scientific entrepreneurship and technology transfer.
This continuous flow of talent and innovation reinforces the competitiveness of the sector.
Galicia has distinctive capabilities in key areas such as:
In addition to public strategies, the sector has attracted more than €165 million in capital investment, with a growing number of transactions and specialized vehicles, consolidating Galicia as a strategic destination for investment in biotechnology.
The combination of talent, knowledge, institutional support, and market opportunities positions Galicia as a strategic destination for investment in biotechnology.
